Prenatal exposure to endocrine-disrupting chemicals (EDCs) exerts both short- and long-term adverse effects on the developing fetus. However, the mechanisms underlying these effects have yet to be uncovered. Maternal–fetal signaling is mediated in part by signaling molecules (eg, microRNAs [miRNAs]) contained in extracellular vesicles (EVs) that are released by the placenta into the maternal circulation. We investigated whether maternal exposure to the EDCs phthalates and personal care products alters the miRNA profile of placental-derived EVs circulating in maternal blood. Blood and urine samples from pregnant women with uncomplicated term dichorionic, diamniotic twin pregnancies were analyzed as part of a larger study investigating correlations between exposure of phthalate and personal care products and epigenetic alterations in twin pregnancies. We explored correlations between maternal urinary levels of 13 phthalate and 12 personal care products metabolites and the miRNA profile of placental EVs (EV-miRNAs) circulating in maternal blood. The expression of miR-518e was highest among women with high urinary levels of monobenzyl phthalate and methyl paraben. miR-373-3p was the least expressed in women exposed to high levels of methyl paraben, and miR-543 was significantly downregulated in women exposed to high levels of paraben metabolites, dichlorophenol metabolites, and triclosan. In conclusion, this pilot study reveals that prenatal exposure to EDCs is associated with altered profile of circulating placenta-derived EV-miRNAs. Further studies are needed to generalize these results to singleton pregnancies and to assess whether these alterations are associated with pregnancy complications.
GoldenRGandyJVollmerG. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit Rev Toxicol. 2005;35(
5
):435–458.
2.
HauserRCalafatAM. Phthalates and human health. Occup Environ Med. 2005;62(
11
):806–818.
3.
VandenbergLNHauserRMarcusMOleaNWelshonsWV. Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007;24(
2
):139–177.
4.
BermanTHochner-CelnikierDCalafatAM. Phthalate exposure among pregnant women in Jerusalem, Israel: results of a pilot study. Environ Int. 2009;35(
2
):353–357.
5.
CalafatAMYeXWongLYBishopAMNeedhamLL. Urinary concentrations of four parabens in the U.S. population: NHANES 2005-2006. Environ Health Perspect. 2010;118(
5
):679–685.
6.
Tefre de Renzy-MartinKFrederiksenHChristensenJS. Current exposure of 200 pregnant Danish women to phthalates, parabens and phenols. Reproduction. 2014;147(
4
):443–453.
7.
WolffMSEngelSMBerkowitzGS. Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect. 2008;116(
8
):1092–1097.
8.
WoodruffTJZotaARSchwartzJM. Environmental chemicals in pregnant women in the US: NHANES 2003-2004. Environ Health Perspect. 2011;119(
6
):878–885. doi:10.1289/ehp.1002727.
9.
LiuJLiJWuY. Bisphenol A metabolites and bisphenol S in paired maternal and cord serum. Environ Sci Technol. 2017;51(
4
):2456–2463.
10.
MoseTMortensenGKHedegaardMKnudsenLE. Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta tissue and umbilical cord blood. Reprod Toxicol. 2007;23(
1
):83–91.
11.
DannABHontelaA. Triclosan: environmental exposure, toxicity and mechanisms of action. J Appl Toxicol. 2011;31(
4
):285–311.
12.
KrauseMKlitABlomberg JensenM. Sunscreens: are they beneficial for health? An overview of endocrine disrupting properties of UV-filters. Int J Androl. 2012;35(
3
):424–436.
13.
TalsnessCEAndradeAJKuriyamaSNTaylorJAvom SaalFS. Components of plastic: experimental studies in animals and relevance for human health. Philos Trans R Soc Lond B Biol Sci. 2009;364(
1526
):2079–2096.
14.
AmbrosV. microRNAs: tiny regulators with great potential. Cell. 2001;107(
7
):823–826.
15.
MitchellMDPeirisHNKobayashiM. Placental exosomes in normal and complicated pregnancy. Am J Obstet Gynecol. 2015;213(
4 suppl
): S173–S181.
16.
SilvaMJSamandarEPreauJLJrReidyJANeedhamLLCalafatAM. Quantification of 22 phthalate metabolites in human urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;860(
1
):106–112.
17.
YeXKuklenyikZNeedhamLLCalafatAM. Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem. 2005;77(
16
):5407–5413.
18.
CavalleriTAngeliciLFaveroC. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease. PLoS One. 2017;12(
5
):e0176680.
19.
AndersenCLJensenJLOrntoftTF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64(
15
):5245–5250.
20.
VandesompeleJDe PreterKPattynF. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.
21.
LivakKJSchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(
4
):402–408.
22.
FuGYeGNadeemLJiL. MicroRNA-376c impairs transforming growth factor-beta and nodal signaling to promote trophoblast cell proliferation and invasion. Hypertension. 2013;61(
4
):864–872.
23.
HiuraHHattoriHKobayashiN. Genome-wide microRNA expression profiling in placentae from frozen-thawed blastocyst transfer. Clin Epigenetics. 2017;9:79.
24.
Laresgoiti-ServitjeE. Pregnancy-related miRNAs participate in the regulation of the immune system during the gestational period. J Clin Cell Immunol. 2015;6(
5
):1000361.
25.
LaRoccaJBinderAMMcElrathTFMichelsKB. First-trimester urine concentrations of phthalate metabolites and phenols and placenta miRNA expression in a cohort of U.S. women. Environ Health Perspect. 2016;124(
3
):380–387.
26.
VashukovaESGlotovASFedotovPV. Placental microRNA expression in pregnancies complicated by superimposed preeclampsia on chronic hypertension. Mol Med Rep. 2016;14(
1
):22–32.
27.
BoenigerMFLowryLKRosenbergJ. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J. 1993;54(
10
):615–627.
YangSLiHGeQGuoLChenF. Deregulated microRNA species in the plasma and placenta of patients with preeclampsia. Mol Med Rep. 2015;12(
1
):527–534.
31.
WernerEFBraunJMYoltonKKhouryJCLanphearBP. The association between maternal urinary phthalate concentrations and blood pressure in pregnancy: the HOME study. Environ Health. 2015;14:75.
32.
Delorme-AxfordEDonkerRBMouilletJF. Human placental trophoblasts confer viral resistance to recipient cells. Proc Natl Acad Sci U S A. 2013;110(
29
):12048–12053.
33.
ZhouADDiaoLTXuH. Beta-catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/beta-catenin-signaling pathway. Oncogene. 2012;31(
24
):2968–2978.
34.
ChenYLuoJTianRSunHZouS. miR-373 negatively regulates methyl-CpG-binding domain protein 2 (MBD2) in hilar cholangiocarcinoma. Dig Dis Sci. 2011;56(
6
):1693–1701.
35.
WeiFCaoCXuXWangJ. Diverse functions of miR-373 in cancer. J Transl Med. 2015;13:162.
36.
ZhangHGuoXFengX. MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1alpha protein. Oncotarget. 2017;8(
2
):2342–2355.
37.
MeruvuSZhangJBediYSChoudhuryM. Mono-(2-ethylhexyl) phthalate induces apoptosis through miR-16 in human first trimester placental cell line HTR-8/SVneo. Toxicol In Vitro. 2016;31:35–42.
38.
Avissar-WhitingMVeigaKR. Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol. 2010;29(
4
):401–406.
39.
EndzelinsEBergerAMelneV. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients. BMC Cancer. 2017;17(
1
):730.
40.
GunelTHosseiniMKGumusogluEKisakesenHIBenianAAydinliK. Expression profiling of maternal plasma and placenta microRNAs in preeclamptic pregnancies by microarray technology. Placenta. 2017;52:77–85.
41.
HosseiniMKGunelTGumusogluEBenianAAydinliK. MicroRNA expression profiling in placenta and maternal plasma in early pregnancy loss. Mol Med Rep. 2018;17(
4
):4941–4952. doi:10.3892/mmr.2018.8530.
42.
LiQLongAJiangL. Quantification of preeclampsia-related microRNAs in maternal serum. Biomed Rep. 2015;3(
6
):792–796.
